Clinical Trial Update: Nicotinamide in Hemodialysis Patients With Hyperphosphatemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nicotinamide for hyperphosphatemia in patients on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Medice Arzneimittel Pütter GmbH & Co KG | Conditions: Chronic Kidney Disease, Hemodialysis | Phase 2 | Status: COMPLETED